Two cheap jerseys months cheap nba jerseys into cheap jerseys PHCN‘s Yet Treatment Information K?benhavns Project and the information embodying the resource has been changed and updated numerous times. One Friday afternoon, for example, was spent updating the project’s Drug Pipeline Diagram, only to realize that the new updates were already out of dated and that the work had to be redone.
With all of the changes taking place around treatment for hepatitis C, it’s an exciting time to be following the upcoming drugs through the drug approval process in Canada and BC.
During the past summer, for example, one of the drugs, Incivek, which had once emerged with promise in the fight against hepatitis C but required interferon, was discontinued by its maker, Vertex, as newer, improved therapies, not requiring interferon, advanced.
This announcement came on the heels of Vertex’s earlier announcement that it was ending its hep C research and development program.
But it’s not just an exciting time to watch and wait as the next generation of therapies advance through the drug pipeline, it’s also a great time to get involved, have your voice heard, and possibly help as decisions are made regarding newly emerging drugs!
On that note, PHCN requires survey participants with hep C or living with/caring for someone with hep C ASAP!
The survey’s link is: http://www.fluidsurveys.com/s/CADTH_Led_Sof_PHCN/
The survey includes 36, mostly multiple choice, questions that are divided into 5 sections. The sections that don’t pertain to you can be easily skipped. The survey’s 5 sections ask about:
- The impact of hep C on your life (8 questions)
- Your experience with current hep C treatments (9 questions)
- The impact on caregivers (4 questions)
- Your expectations and experience with Harvoni (ledipasvir/sofosbuvir) after taking the treatment (10 questions)
- Your expectations of (Harvoni) ledipasvir/sofosbuvir (5 questions)
Survey responses are anonymous (we don’t know your name or other information about you). The information gathered will be used as part of a patient group input report about the above topics for the Canadian Agency for Drugs and Technologies in Health (CADTH). By completing the survey you accept that Pacific Hepatitis C Network (PHCN) can use the information gathered in the survey in our patient group input report for CADTH.
The patient group input reports requested by CADTH are an important step towards getting new treatments for hep C more widely available in Canada and BC. You can be a part of this process!
Please email firstname.lastname@example.org for more information.
Thank you for taking the time to voice your opinion and help advocate for a better tomorrow!